Profile of blonanserin for the treatment of schizophrenia
Tomomi Tenjin, Seiya Miyamoto, Yuriko Ninomiya, Rei Kitajima, Shin Ogino, Nobumi Miyake, Noboru YamaguchiDepartment of Neuropsychiatry, St Marianna University School of Medicine, Kawasaki, Kanagawa, JapanAbstract: Blonanserin was developed as an antipsychotic drug in Japan and approved for the treat...
Enregistré dans:
Auteurs principaux: | Tenjin T, Miyamoto S, Ninomiya Y, Kitajima R, Ogino S, Miyake N, Yamaguchi N |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e302a7e69eba4fb2b7c5fc3a1d82f6ed |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Early prediction of blonanserin response in Japanese patients with schizophrenia
par: Kishi T, et autres
Publié: (2014) -
A randomized trial of aripiprazole vs blonanserin for the treatment of acute schizophrenia and related disorders
par: Kishi T, et autres
Publié: (2016) -
Profile of minocycline and its potential in the treatment of schizophrenia
par: Zhang L, et autres
Publié: (2014) -
Blonanserin treatment in patients with methamphetamine-induced psychosis comorbid with intellectual disabilities
par: Okazaki K, et autres
Publié: (2016) -
Role of aripiprazole in treatment-resistant schizophrenia
par: Mossaheb N, et autres
Publié: (2012)